Clinical trial
Phase 1, Multicenter, Open-Label, First-in-Human Study of DS-6157a in Subjects With Advanced Gastrointestinal Stromal Tumor
NCT04276415 is registered in ClinicalTrials.gov with Daiichi Sankyo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 1, Multicenter, Open-Label, First-in-Human Study of DS-6157a in Subjects With Advanced Gastrointestinal Stromal Tumor
- Lead sponsor
- Daiichi Sankyo
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- May 8, 2020
- Completion date
- March 11, 2022
- Enrollment
- 34 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.